Close Menu

This article has been updated with information from Roche's earnings presentation.

NEW YORK (GenomeWeb) – Roche today reported that its 2016 diagnostics revenues grew 6 percent year over year, driven by strong immunodiagnostics product sales within its centralized and point-of-care solutions business.

The company reported CHF 50.58 billion ($51.09 billion) in 2016 revenues, up 5 percent from CHF 48.15 billion in 2015. At constant exchange rates, the firm's revenues grew 4 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.